LINAC devices market forecast to reach $8.48 billion by 2030

The LINAC devices market is projected to grow from $5.48 billion in 2025 to $5.96 billion in 2026, with longer-term forecasts calling for $8.48 billion by 2030. The report points to rising cancer incidence, AI-assisted radiotherapy and compact systems as key forces shaping demand.

Why it matters: - LINAC devices are central to radiation therapy for cancer, so market growth tracks a broader rise in cancer treatment demand and investment in oncology infrastructure. - The forecast points to sustained expansion in precision oncology, where better targeting can improve outcomes and reduce harm to healthy tissue.

What happened: - The Business Research Company released its "LINAC Devices Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report estimates the global LINAC devices market will rise from $5.48 billion in 2025 to $5.96 billion in 2026. - The report projects the market will reach $8.48 billion by 2030. - The release is dated August 14, 2026, in London.

The details: - The report puts the market's 2025-2026 growth rate at 8.9%. - It projects a 9.2% CAGR through 2030. - Growth drivers include expansion of cancer treatment infrastructure, rising global cancer burden, wider adoption of advanced radiotherapy, more oncology specialists and improved radiation accuracy. - Forward demand is expected to be supported by investment in precision oncology and personalized cancer therapies. - The report also cites AI-powered radiotherapy planning, broader access in emerging economies and growing interest in compact LINAC systems. - Key market trends include greater use of image-guided radiation therapy, wider adoption of high-energy LINAC devices, modular and compact designs, and a stronger focus on precise radiation dosing. - LINAC stands for linear accelerator, a device that accelerates charged particles in a straight line. - In medicine, LINACs generate high-energy electron or X-ray beams to target cancerous tumors. - The report says this approach helps focus radiation on tumors while sparing nearby healthy tissue. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, a company scoring matrix, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The report also includes key technology analysis and future trend analysis. - A free sample is available here. - The full report is available here. - The company listed LinkedIn at The Business Research Company.

Between the lines: - The report frames cancer prevalence as the central demand driver, linking market growth to diagnosis volume, treatment capacity and technology upgrades. - The emphasis on AI, compact systems and modular designs suggests suppliers are competing on access, efficiency and precision, not just installed base. - Regional growth patterns show mature markets still dominate revenue while emerging markets may offer faster unit growth.

What's next: - The report expects broader adoption of AI-assisted planning and image-guided radiotherapy to continue over the forecast period. - Expansion in emerging economies is likely to remain a key growth lever as more hospitals add radiotherapy capacity. - Compact LINAC designs may open more use cases in smaller or resource-limited facilities.

The bottom line: - LINAC devices are moving from a steady oncology niche to a faster-growing global market, powered by cancer demand, precision medicine and technology upgrades.